Trade Summary

3 days ago, Pelish Henry E., serving as Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 2,111 shares at $123.81 per share, for a total transaction value of $261,362.91. Following this transaction, Pelish Henry E. now holds 63,493 shares of NUVL.

This sale represents a 3.22% decrease in Pelish Henry E.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 9, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 10, 2026 at 4:30 PM ET, 1 day after the trade was made.

Nuvalent, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.